4-(4-Hydroxyphenyl)-2-butanone
Common Name: |
4-(4-Hydroxyphenyl)-2-butanone |
IUPAC Name: |
4-(4-hydroxyphenyl)butan-2-one |
Molecular Formula: |
C4H8S2 |
SMILES: |
CC(=O)CCC1=CC=C(C=C1)O |
Inchi: |
1S/C10H12O2/c1-8(11)2-3-9-4-6-10(12)7-5-9/h4-7,12H,2-3H2,1H3 |
Inchi Key: |
NJGBTKGETPDVIK-UHFFFAOYSA-N |
Cas No: |
5471-51-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
120.24 |
Mass (g/mol) |
164.084 |
Molar Refractivity |
34.41 |
Net Charge |
|
HBD |
|
HBA |
0 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
50.60 |
Hetero Atoms |
2 |
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
82.5 |
Boiling Point (°C@760.00mm Hg) |
200.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.001 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
1.914 |
iLOGP |
1.77 |
XLOGP3 |
1.83 |
WLOGP |
1.81 |
MLOGP |
1.42 |
ESOL Log S |
-1.74 |
ESOL Solubility (mg/ml) |
2.2 |
ESOL Solubility (mol/l) |
0.018 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.51 |
Ali Solubility (mg/ml) |
0.37 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.04 |
Silicos-IT Solubility (mg/ml) |
11 |
Silicos-IT Solubility (mol/l) |
0.09 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.73 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.447 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.483 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |